Proteasome activation and nNOS down-regulation in neuroblastoma cells expressing a Cu,Zn superoxide dismutase mutant involved in familial ALS

被引:40
作者
Aquilano, K [1 ]
Rotilio, G [1 ]
Ciriolo, MR [1 ]
机构
[1] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy
关键词
amyotrophic lateral sclerosis; carbonyls; neuronal nitric oxide synthase; nitric oxide; proteasome; reactive oxygen species;
D O I
10.1046/j.1471-4159.2003.01783.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Reactive oxygen and nitrogen species have emerged as predominant effectors of neurodegeneration. We demonstrated that expression of the fully active G93A Cu,Zn superoxide dismutase mutant in neuroblastoma cells is associated with an increased level of oxidatively modified proteins, in terms of carbonylated residues. A parallel increase in proteasome activity was detected and this was mandatory in order to assure cell viability. In fact, proteasome inhibition by lactacystin or MG132 resulted in programmed cell death. Nitrosative stress was not involved in the oxidative unbalance, as a decrease in neuronal nitric oxide production and down-regulation of neuronal nitric oxide synthase (nNOS) level were detected. The nNOS down-regulation was correlated to increased proteolytic degradation by proteasome, because comparable levels of nNOS were detected in G93A and parental cells upon treatment with lactacystin. The altered rate of proteolysis observed in G93A cells was specific for nNOS as Cu,Zn superoxide dismutase (Cu,Zn SOD) degradation by proteasome was influenced neither by its mutation nor by increased proteasome activity. Treatment with the antioxidant 5,5'-dimethyl-1-pyrroline N -oxide resulted in inhibition of protein oxidation and decrease in proteasome activity to the basal levels. Overall these results confirm the pro-oxidant activity of G93A Cu,Zn SOD mutant and, at the same time, suggest a cross-talk between reactive oxygen and nitrogen species via the proteasome pathway.
引用
收藏
页码:1324 / 1335
页数:12
相关论文
共 57 条
[21]   Antioxidants, oxidative stress, and degenerative neurological disorders [J].
Floyd, RA .
PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1999, 222 (03) :236-245
[22]   Fundamental aspects of reactive oxygen species, or what's the matter with oxygen? [J].
Fridovich, I .
OXIDATIVE/ENERGY METABOLISM IN NEURODEGENERATIVE DISORDERS, 1999, 893 :13-18
[23]   DISPLACEMENT OF HOUSEKEEPING PROTEASOME SUBUNITS BY MHC-ENCODED LMPS - A NEWLY DISCOVERED MECHANISM FOR MODULATING THE MULTICATALYTIC PROTEINASE COMPLEX [J].
FRUH, K ;
GOSSEN, M ;
WANG, KN ;
BUJARD, H ;
PETERSON, PA ;
YANG, Y .
EMBO JOURNAL, 1994, 13 (14) :3236-3244
[24]   Calpain activation in Huntington's disease [J].
Gafni, J ;
Ellerby, LM .
JOURNAL OF NEUROSCIENCE, 2002, 22 (12) :4842-4849
[25]   'Oxidation inhibits substrate proteolysis by calpain I but not autolysis [J].
Guttmann, RP ;
Elce, JS ;
Bell, PD ;
Isbell, JC ;
Johnson, GVW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (03) :2005-2012
[26]  
HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1
[27]   Hypothesis: Proteasomal dysfunction - A primary event in neurogeneration that leads to nitrative and oxidative stress and subsequent cell death [J].
Halliwell, B .
NITRIC OXIDE: NOVEL ACTIONS, DELETERIOUS EFFECTS AND CLINICAL POTENTIAL, 2002, 962 :182-194
[28]   Redox regulation of signal transduction in mammalian cells [J].
Herrlich, P ;
Böhmer, FD .
BIOCHEMICAL PHARMACOLOGY, 2000, 59 (01) :35-41
[29]   Impaired proteasome function in Alzheimer's disease [J].
Keller, JN ;
Hanni, KB ;
Markesbery, WR .
JOURNAL OF NEUROCHEMISTRY, 2000, 75 (01) :436-439
[30]   Possible involvement of proteasome inhibition in aging: implications for oxidative stress [J].
Keller, JN ;
Hanni, KB ;
Markesbery, WR .
MECHANISMS OF AGEING AND DEVELOPMENT, 2000, 113 (01) :61-70